The trajectory of Sildenafil presents a challenging picture for investors. escort While the initial release generated significant profits, the expiration of its intellectual property protection opened the floodgates to off-brand alternatives, dramatically eroding market share. This poses a unique challenge for firms banking on similar blockbuster p
copyright's Pill and the Pharmaceutical Sector : A Risky Investment ?
The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, producing billions in sales , its exclusivity period created a flood of generic competition , significantly eroding its dominance. While specific pharmaceutical companies may attempt to capitalize on male sexual dysfunction